TMBC Monthly Newsletter, March 2018, V15
|
|
Every month The Microbiome Coalition (TMBC) will bring you the latest in research, news and information to keep you up to date on the microbiome industry.
We welcome your feedback and suggestions for content.
Follow us on Twitter, @TMBCoalition
|
|
Exciting New TMBC Updates!
|
|
Developing IP in the Microbiome Space: Newly-Published White Paper
In collaboration with Nixon Peabody LLP and ICOSA, TMBC have developed a white paper providing an overview of the microbiome industry with a special emphasis on obtaining and protecting intellectual property in the space. We are excited to formally share this with you. You can access and download our white paper
here
.
Our Latest Speed Round Interview
We are excited to share our most recent
Speed Round
interview with Peter Christey, CEO of General Automation Lab Technologies (GALT). Our question for him: do we need to expand beyond sequencing as the primary tool for studying the microbiome? See full interview
here
|
|
Microbiome in the Spotlight
|
|
4th Annual Arrowhead Translational Microbiome Conference, Boston, MA, April 18-20
As the official conference of The Microbiome Coalition (TMBC) the Arrowhead conference
brings together senior executives and top decision-makers in the industry to advance our understanding of the hurdles and challenges to commercial success in the space.
Now in its fourth year, the Arrowhead conference features several in-depth, interactive pre-conference workshops and a main track focused across therapies and disease states. In addition, two parallel tracks, the first focused on the microbiome in the built environment, sponsored by Reckitt Benckiser and the second focused on the microbiome and nutrition, sponsored by Nestle Health Sciences.
|
|
With $36M Series B, Finch Goes Full Speed Ahead in Microbiome Therapy
Finch Therapeutics, a privately held microbiome therapeutics company, announced the successful close of an oversubscribed $36 million Series B financing, bringing the total capital raised since the Company’s launch to $77 million. Investors in the Series B include Shumway Capital, Willet Advisors, Morgan Noble and Avenir Growth Capital. Full press release
here
DuPont’s Microbiome Venture Announces Second Strategic Partnership
Three months after its formation, the DuPont Nutrition & Health Microbiome Venture today announced its second strategic research and development partnership. The newly forged relationship with the Center of Food and Fermentation Technologies (TFTAK) in Tallinn, Estonia, will focus on developing cultivation and bioprocess capabilities for “next-generation” probiotics. Full press release
here
The Forsyth Institute Expands Key Human Microbiome Database
A team of researchers from The Forsyth Institute, a global leader in oral health research, today announced they have added over 80 species to generate the expanded Human Oral Microbiome Database (eHOMD), an online index of microbial species present in the mouth and respiratory tract, including the nasal passages and throat. Full press release
here
|
|
Microbiome Cycles Revealed by Low-Cost Gnotobiotic Cages
While developing a low-cost alternative to traditional gnotobiotic isolators, a team of researchers at Case Western Reserve University (CWRU) were able to characterize cyclical changes in the microbiomes of gnotobiotic mice. Their research has implications for both the design and affordability of gnotobiotic animal model research. Full article
here
FDA Clears Clinical Studies for New Bacteriophage Treatment for Crohn’s Disease
The U.S. FDA gave its seal of approval to a new Phase 1/2 clinical trial in humans at Mount Sinai hospital in NYC to test a new bacteriophage treatment for Crohn's disease. It would be one of the first investigational new drug (IND) applications ever approved for bacteriophages by the FDA and is also the first approved to target what is known as adhesive invasive E. coli (AIEC), a strain of bacteria that can be found in people who have Crohn's. Full article
here
Global Virome Project Will Spend Next 10 Years Identifying Unknown Viruses in the Wild
Following recent outbreaks of viruses such as Zika and Ebola, public health researchers are increasingly working to discover new viruses before they emerge and cause human outbreaks. To meet that goal, this year will mark the launch of the Global Virome Project. Full article
here
|
|
Microbiome-Inspired Artwork Brings "Echoes of DNA" to University of Buffalo’s New Medical School Building
The more O’Leary-Soudant learned, the more interested she became in the emerging field of the microbiome and the concept that survival depends to a large extent on good bacteria. “That idea of beneficial bacteria became the centerpiece of what I was trying to achieve,” she explains. Full article
here
|
|
Clinical Coordinator, Whole Biome
Whole Biome is currently seeking a Clinical Coordinator to join their Clinical Team. As Clinical Coordinator, you work directly with the Chief Medical Officer to provide the project management support for all Whole Biome clinical studies. Learn more
here
Inside Sales Representative, CosmosID
CosmosID is recruiting an Inside Sales Representative to support their sales, marketing, and overall growth of the business. This position is for someone who is driven, organized, embraces change, and is very willing to learn in a field that is constantly evolving. Learn more
here
Director of Quality Assurance, Second Genome
They’re looking for someone ready to take on responsibility for the strategy, implementation and leadership of the Quality organization. They are looking for this role to be accountable for the continuous development, execution and administration of a comprehensive GxP Quality System that meets all compliance requirements pertaining to Good Laboratory Practices (GLP), Good Clinical Practices (GCP) and Good Manufacturing Practices (GMP), ICH and EMA regulations. Learn more
here
|
|
4th Annual Translational Microbiome Conference
The conference will once again bring together the top companies in the microbiome space working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products. Boston, MA. Apr 18-20.
https://www.microbiomeconference.com
Microbiome Futures: A Global Translational Roadmap
The live event will be the culmination of a thorough research process during which the working group will be gathering input from a global pool of stakeholders in the microbiome space. They will come prepared, having researched and discussed issues from the science of moving from correlation to causation to practical solutions to data and regulatory hurdles. New York, New York. May 23.
http://www.global-engage.com/event/microbiome-futures/
Microbiome Invest Congress 2018
This event is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space. London, United Kingdom. May 23.
https://microbiomeinvest.com/events/microbiome-invest
|
|
Microbiome Awards, Fellowships, and Prizes
|
|
QIAGEN 2018 Microbiome Awards
These awards provides young, extraordinary scientists with funding and recognition to carry out scientific work in the field of Microbiome research. QIAGEN, the main sponsor of the award, is generously donating a prize package for the 2018 Microbiome Awards. This year's awards will be open to scientists who received their PhD in 2008 or later and will also include a new category for PhD students. Applications will be accepted beginning in May 2018. Learn more about the opportunity
here
|
|
Consider joining the coalition. Members of TMBC participate on our committees, attend our events, generate networking and business development opportunities and, most importantly, contribute to the growth and success of a unique organization that is positioned to ensure that public opinion and policy pave the way for microbiome based therapeutics, diagnostics and direct-to-consumer services and products.
Membership Categories
• Sole proprietor (legal, consulting, other) • Academic and clinical institutions
• Patient advocacy groups • Industry/trade associations
• Corporations (pharmaceutical, diagnostic,bioinformatics, other)
Benefits of Membership
• Shape the Future of Microbiome Policy • Curated research library
• Monthly newsletter • White papers • Extended network • Job listings • Event listings
See our
flyer
for more details
|
|
Promoting Greater Understanding of the Role
of the Microbiome in Human Health and Wellness
|
|
|
|
|
|
|
